Posted by Michael Wonder on 17 Jul 2018
CVS Health responds to request for information on Trump administration's blueprint to lower drug prices
16 July 2018 - Company underscores support for the Administration's goal and outlines steps it has taken to hold down drug costs for consumers.
CVS Health today submitted its comments in response to the request for information on the Trump Administration's Blueprint to Lower Drug Prices.
In a cover letter to Secretary of Health and Human Services Alex Azar summarising the full comments submitted to HHS, the company underscored support for the Administration's goals and emphasised the industry-leading steps it has taken to hold down drug costs and bring innovative solutions to market to help consumers.
